Identification of miRNA-103 in the cellular fraction of human peripheral blood as a potential biomarker for malignant mesothelioma--a pilot study.

by Daniel G Weber, Georg Johnen, Oleksandr Bryk, Karl-Heinz Jöckel, Thomas Brüning
Published 2012-01-01

Re-evaluation of potential predictors of calretinin and mesothelin in a population-based cohort study using assays for the routine application in clinical medicine

by Daniel Weber, Swaantje Casjens, Georg Johnen, Irina Raiko, Dirk Taeger, Carmen Töpfer, Sandra Schonefeld
Published 2021-02-01

Evaluation of a New Survivin ELISA and UBC® Rapid for the Detection of Bladder Cancer in Urine

by Jan Gleichenhagen, Christian Arndt, Swaantje Casjens, Carmen Meinig, Holger Gerullis, Irina Raiko, Thomas Brüning, Thorsten Ecke, Georg Johnen
Published 2018-01-01

Combination of MiR-103a-3p and mesothelin improves the biomarker performance of malignant mesothelioma diagnosis.

by Daniel G Weber, Swaantje Casjens, Georg Johnen, Oleksandr Bryk, Irina Raiko, Beate Pesch, Jens Kollmeier, Torsten T Bauer, Thomas Brüning
Published 2014-01-01

Assessment of Confounding Factors Affecting the Tumor Markers SMRP, CA125, and CYFRA21-1 in Serum

by Daniel Gilbert Weber, Georg Johnen, Dirk Taeger, Anne Weber, Isabelle Mercedes Gross, Beate Pesch, Thomas Kraus, Thomas Brüning, Monika Gube
Published 2010-01-01

NOTCH1, HIF1A and other cancer-related proteins in lung tissue from uranium miners--variation by occupational exposure and subtype of lung cancer.

by Beate Pesch, Swaantje Casjens, Ingo Stricker, Daniela Westerwick, Dirk Taeger, Sylvia Rabstein, Thorsten Wiethege, Andrea Tannapfel, Thomas Brüning, Georg Johnen
Published 2012-01-01

Determinants of plasma calretinin in patients with malignant pleural mesothelioma

by Martin Lehnert, Daniel G. Weber, Dirk Taeger, Irina Raiko, Jens Kollmeier, Susann Stephan-Falkenau, Thomas Brüning, Georg Johnen, the MoMar-Study Group
Published 2020-07-01

Assessment of Confounding Factors Affecting the Tumor Markers SMRP, CA125, and CYFRA21-1 in Serum

by Daniel Gilbert Weber, Georg Johnen, Dirk Taeger, Anne Weber, Isabelle Mercedes Gross, Beate Pesch, Thomas Kraus, Thomas Brüning, Monika Gube
Published 2010-01-01

Digital PCR for the Analysis of MYC Copy Number Variation in Lung Cancer

by Alexander Brik, Daniel G. Weber, Swaantje Casjens, Peter Rozynek, Swetlana Meier, Thomas Behrens, Georgios Stamatis, Kaid Darwiche, Dirk Theegarten, Thomas Brüning, Georg Johnen
Published 2020-01-01

Are circulating microRNAs suitable for the early detection of malignant mesothelioma? Results from a nested case–control study

by Daniel Gilbert Weber, Alexander Brik, Swaantje Casjens, Katarzyna Burek, Martin Lehnert, Beate Pesch, Dirk Taeger, Thomas Brüning, Georg Johnen, the MoMar study group
Published 2019-02-01

Circulating miR-132-3p as a Candidate Diagnostic Biomarker for Malignant Mesothelioma

by Daniel G. Weber, Katarzyna Gawrych, Swaantje Casjens, Alexander Brik, Martin Lehnert, Dirk Taeger, Beate Pesch, Jens Kollmeier, Torsten T. Bauer, Georg Johnen, Thomas Brüning
Published 2017-01-01

Circulating long non-coding RNA GAS5 (growth arrest-specific transcript 5) as a complement marker for the detection of malignant mesothelioma using liquid biopsies

by Daniel G. Weber, Swaantje Casjens, Alexander Brik, Irina Raiko, Martin Lehnert, Dirk Taeger, Jan Gleichenhagen, Jens Kollmeier, Torsten T. Bauer, Thomas Brüning, Georg Johnen, the MoMar study group
Published 2020-05-01

Assessment of mRNA and microRNA Stabilization in Peripheral Human Blood for Multicenter Studies and Biobanks

by Daniel Gilbert Weber, Swaantje Casjens, Peter Rozynek, Martin Lehnert, Sandra Zilch-Schöneweis, Oleksandr Bryk, Dirk Taeger, Maria Gomolka, Michaela Kreuzer, Heinz Otten, Beate Pesch, Georg Johnen, Thomas Brüning
Published 2010-01-01

Assessment of mRNA and microRNA Stabilization in Peripheral Human Blood for Multicenter Studies and Biobanks

by Beate Pesch, Heinz Otten, Michaela Kreuzer, Maria Gomolka, Dirk Taeger, Oleksandr Bryk, Sandra Zilch- Schöneweis, Peter Rozynek, Martin Lehnert, Swaantje Casjens, Daniel Gilbert Weber, Georg Johnen, Thomas Brüning
Published 2010-09-01

Cross-contamination of a UROtsa stock with T24 cells--molecular comparison of different cell lines and stocks.

by Georg Johnen, Peter Rozynek, Yvonne von der Gathen, Oleksandr Bryk, Ricarda Zdrenka, Christian Johannes, Daniel G Weber, O Brien Igwilo-Okuefuna, Irina Raiko, Jörg Hippler, Thomas Brüning, Elke Dopp
Published 2013-01-01

Performance of survivin mRNA as a biomarker for bladder cancer in the prospective study UroScreen.

by Georg Johnen, Katarzyna Gawrych, Heike Bontrup, Beate Pesch, Dirk Taeger, Séverine Banek, Matthias Kluckert, Harald Wellhäußer, Friedhelm Eberle, Michael Nasterlack, Gabriele Leng, Arnulf Stenzl, Thomas Brüning, UroScreen Study Group
Published 2012-01-01

Calretinin as a blood-based biomarker for mesothelioma

by Georg Johnen, Katarzyna Gawrych, Irina Raiko, Swaantje Casjens, Beate Pesch, Daniel G. Weber, Dirk Taeger, Martin Lehnert, Jens Kollmeier, Torsten Bauer, Arthur W. Musk, Bruce W. S. Robinson, Thomas Brüning, Jenette Creaney
Published 2017-05-01

Prognostic Role of Survivin and Macrophage Infiltration Quantified on Protein and mRNA Level in Molecular Subtypes Determined by RT-qPCR of <i>KRT5</i>, <i>KRT20</i>, and <i>ERBB2<...

by Thorsten H. Ecke, Adisch Kiani, Thorsten Schlomm, Frank Friedersdorff, Anja Rabien, Klaus Jung, Ergin Kilic, Peter Boström, Minna Tervahartiala, Pekka Taimen, Jan Gleichenhagen, Georg Johnen, Thomas Brüning, Stefan Koch, Jenny Roggisch, Ralph M. Wirtz
Published 2020-10-01